Crescendo Health aggregates and normalizes data from patient access APIs, health records, lab results, and third-party sources to give life sciences companies a research-grade view of individual patients. The sponsor-facing portal supports patient selection, regulatory filings, and billing, streamlining the historically costly trial recruitment process.

Sam Roosz, the CEO, is the former co-founder of Datavant, which merged with Ciox Health for $7 billion. Crescendo Health is solving the expensive process of identifying and recruiting patients for clinical trials, a critical need where complex tech and regulatory compliance create significant barriers to entry.